Correlation Between Fresenius Medical and Companhia Siderrgica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fresenius Medical and Companhia Siderrgica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fresenius Medical and Companhia Siderrgica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fresenius Medical Care and Companhia Siderrgica Nacional, you can compare the effects of market volatilities on Fresenius Medical and Companhia Siderrgica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fresenius Medical with a short position of Companhia Siderrgica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fresenius Medical and Companhia Siderrgica.

Diversification Opportunities for Fresenius Medical and Companhia Siderrgica

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Fresenius and Companhia is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Fresenius Medical Care and Companhia Siderrgica Nacional in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Companhia Siderrgica and Fresenius Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fresenius Medical Care are associated (or correlated) with Companhia Siderrgica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Companhia Siderrgica has no effect on the direction of Fresenius Medical i.e., Fresenius Medical and Companhia Siderrgica go up and down completely randomly.

Pair Corralation between Fresenius Medical and Companhia Siderrgica

Assuming the 90 days trading horizon Fresenius Medical Care is expected to generate 1.01 times more return on investment than Companhia Siderrgica. However, Fresenius Medical is 1.01 times more volatile than Companhia Siderrgica Nacional. It trades about 0.11 of its potential returns per unit of risk. Companhia Siderrgica Nacional is currently generating about -0.18 per unit of risk. If you would invest  11,322  in Fresenius Medical Care on October 26, 2024 and sell it today you would earn a total of  2,367  from holding Fresenius Medical Care or generate 20.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Fresenius Medical Care  vs.  Companhia Siderrgica Nacional

 Performance 
       Timeline  
Fresenius Medical Care 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Fresenius Medical Care are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Fresenius Medical sustained solid returns over the last few months and may actually be approaching a breakup point.
Companhia Siderrgica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Companhia Siderrgica Nacional has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Fresenius Medical and Companhia Siderrgica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fresenius Medical and Companhia Siderrgica

The main advantage of trading using opposite Fresenius Medical and Companhia Siderrgica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fresenius Medical position performs unexpectedly, Companhia Siderrgica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Companhia Siderrgica will offset losses from the drop in Companhia Siderrgica's long position.
The idea behind Fresenius Medical Care and Companhia Siderrgica Nacional pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum